Viva Biotech Holdings (FRA:VB0) EBIT per Share : €0.02 (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings EBIT per Share?

Viva Biotech Holdings's EBIT per Share for the six months ended in Jun. 2024 was €0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.02.

During the past 12 months, the average EBIT per Share Growth Rate of Viva Biotech Holdings was -37.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 13.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 52.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Viva Biotech Holdings's EBIT per Share or its related term are showing as below:

FRA:VB0' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 13.7 Med: 27.8 Max: 94
Current: 13.7

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Viva Biotech Holdings was 94.00% per year. The lowest was 13.70% per year. And the median was 27.80% per year.

FRA:VB0's 3-Year EBIT Growth Rate is ranked better than
57.13% of 1234 companies
in the Biotechnology industry
Industry Median: 7.95 vs FRA:VB0: 13.70

Viva Biotech Holdings's EBIT for the six months ended in Jun. 2024 was €27.8 Mil.

Viva Biotech Holdings EBIT per Share Historical Data

The historical data trend for Viva Biotech Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings EBIT per Share Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.02

0.04

-0.02

0.01

0.02

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial											-0.02	0.01	-	0.01	0.01

Viva Biotech Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Viva Biotech Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	15.492	/	2028.679
=	0.01

Viva Biotech Holdings's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	27.771	/	2141.766
=	0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.02

Viva Biotech Holdings (FRA:VB0) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Viva Biotech Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (FRA:VB0) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

VBIZF:USA 01873:Hong Kong VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.

Viva Biotech Holdings Headlines

No Headlines